# EDGAR Filing Document

**Accession Number:** 0001307954
**File Stem:** 0001104659-23-023462
**Filing Date:** 2023-2
**Character Count:** 42045
**Document Hash:** 476ea3859074ad3de77788fcc17e12c0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-023462.hdr.sgml**: 20230221

**ACCESSION NUMBER**: 0001104659-23-023462

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230221

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230221

**DATE AS OF CHANGE**: 20230221

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Huntsman CORP
- **CENTRAL INDEX KEY:** 0001307954
- **STANDARD INDUSTRIAL CLASSIFICATION:** CHEMICALS & ALLIED PRODUCTS [2800]
- **IRS NUMBER:** 421648585
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-32427
- **FILM NUMBER:** 23645148

**BUSINESS ADDRESS:**
- **STREET 1:** 10003 WOODLOCH FOREST DRIVE
- **CITY:** THE WOODLANDS
- **STATE:** TX
- **ZIP:** 77380
- **BUSINESS PHONE:** (281) 719-6000

**MAIL ADDRESS:**
- **STREET 1:** 10003 WOODLOCH FOREST DRIVE
- **CITY:** THE WOODLANDS
- **STATE:** TX
- **ZIP:** 77380

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **February 21, 2023**

**Huntsman Corporation**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-32427** | **42-1648585** |
| (State or other jurisdiction | (Commission | (IRS Employer |
| of incorporation) | File Number) | Identification No.) |

---

---

| | |
|:---|:---|
| **10003 Woodloch Forest Drive** |  |
| **The Woodlands, Texas** | **77380** |
| (Address of principal executive offices) | (Zip Code) |

---

Registrant's telephone number, including area code:

**(281) 719-6000**

**Not applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below):

◻ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

◻ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

◻ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

◻ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities Registered pursuant to Section 12(b) of the Act:

---

| | | | |
|:---|:---|:---|:---|
| **Registrant** | **Title of each class** | **Trading <br> Symbol** | **Name of each exchange<br> on which registered** |
| Huntsman Corporation | Common Stock, par value $0.01 per share | HUN | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ◻

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

**Item 2.02. Results of Operations and Financial Condition.**

On February 21, 2023, we issued a press release announcing our results for the three months and year ended December 31, 2022. The press release is furnished herewith as Exhibit 99.1.

We will hold a conference call to discuss our fourth quarter and full year 2022 financial results on Tuesday, February 21, 2023, at 10:00 a.m. ET.

Webcast link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=t1RioKDV

Participant dial-in numbers:

Domestic callers: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(877) 402-8037

International callers: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (201) 378-4913

The conference call will be accompanied by presentation slides that will be accessible via the webcast link and Huntsman's investor relations website, www.huntsman.com/investors. Upon conclusion of the call, the webcast replay will be accessible via Huntsman's website.

Information with respect to the conference call, together with a copy of the press release furnished herewith as Exhibit 99.1, is available on the investor relations page of our website at www.huntsman.com/investors.

 **Item 9.01. Financial Statements and Exhibits.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp; Exhibits.

---

| | |
|:---|:---|
| **Number** | **Description of Exhibits** |
| [99.1](tm237357d1_ex99-1.htm) | [Press Release dated February 21, 2023 regarding fourth quarter 2022 earnings](tm237357d1_ex99-1.htm) |
| 104 | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| |
|:---|
| HUNTSMAN CORPORATION |
| /s/ IVAN MARCUSE |
| *Vice President, Investor Relations* |

---

Dated: February 21, 2023

## Exhibit 99.1

**Exhibit 99.1**

![](tm237357d1_ex99-1im001.jpg)

---

| | | |
|:---|:---|:---|
| **FOR IMMEDIATE RELEASE** | **Media:** | **Investor Relations:** |
| February 21, 2023 | Gary Chapman | Ivan Marcuse |
| The Woodlands, TX | (281) 719-4324 | (281) 719-4637 |
| NYSE: HUN | NYSE: HUN | NYSE: HUN |

---

**Huntsman Announces Fourth Quarter 2022 Earnings;**

**Approximately $1.2 Billion in Buybacks and Dividends in 2022;**

**Huntsman Board Approves 12% Dividend Increase**

**Fourth Quarter and Recent Highlights**

&nbsp;&nbsp;&nbsp;&nbsp;**•** Fourth
 quarter 2022 net loss of $91 million compared to net income of $597 million in the prior
 year period; fourth quarter 2022 diluted loss per share of $0.48 compared to diluted earnings
 per share of $2.73 in the prior year period.

&nbsp;&nbsp;&nbsp;&nbsp;**•** Fourth
 quarter 2022 adjusted net income of $8 million compared to adjusted net income of $195 million
 in the prior year period; fourth quarter 2022 adjusted diluted earnings per share of $0.04
 compared to adjusted diluted earnings per share of $0.89 in the prior year period.

&nbsp;&nbsp;&nbsp;&nbsp;**•** Fourth
 quarter 2022 adjusted EBITDA of $87 million compared to adjusted EBITDA of $327 million in
 the prior year period.

&nbsp;&nbsp;&nbsp;&nbsp;**•** Fourth
 quarter 2022 net cash provided by operating activities from continuing operations was $297
 million. Free cash flow from continuing operations was $211 million for the fourth quarter
 2022 compared to free cash flow from continuing operations of $648 million in the prior year
 period.

&nbsp;&nbsp;&nbsp;&nbsp;**•** Repurchased
 approximately 9.1 million shares for approximately $250 million in the fourth quarter 2022.

&nbsp;&nbsp;&nbsp;&nbsp;**•** On
 February 17, 2023, the Board approved a 12% increase to the quarterly dividend.

&nbsp;&nbsp;&nbsp;&nbsp;**•** Huntsman
 has secured all regulatory approvals required to complete the sale of its Textile Effects
 division to Archroma, a portfolio company of SK Capital Partners. The transaction is expected
 to close on February 28, 2023. Huntsman expects the net after tax cash proceeds to be
 approximately $540 million before customary post-closing adjustments.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Twelve months ended** | **Twelve months ended** |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| <br>In millions, except per share amounts | **2022** | **2021** | **2022** | **2021** |
| Revenues | $1650 | $2112 | $8023 | $7670 |
| Net (loss) income attributable to Huntsman Corporation | $(91) | $597 | $460 | $1045 |
| Adjusted net income <sup>(1)</sup> | $8 | $195 | $636 | $726 |
| Diluted (loss) income per share | $(0.48) | $2.73 | $2.27 | $4.72 |
| Adjusted diluted income per share<sup>(1)</sup> | $0.04 | $0.89 | $3.13 | $3.28 |
| Adjusted EBITDA<sup>(1)</sup> | $87 | $327 | $1155 | $1246 |
| Net cash provided by operating activities from continuing operations | $297 | $733 | $892 | $915 |
| Free cash flow from continuing operations<sup>(2)</sup> | $211 | $648 | $620 | $589 |

---

*See end of press release for footnote explanations and reconciliations of non-GAAP measures.*

*THE WOODLANDS, Texas* – Huntsman Corporation (NYSE: HUN) today reported fourth quarter 2022 results with revenues of $1,650 million, net loss of $91 million, adjusted net income of $8 million and adjusted EBITDA of $87 million.

Peter R. Huntsman, Chairman, President, and CEO, commented:

*"In 2022 we delivered almost $1.2 billion of adjusted EBITDA and Free Cash Flow of over $600 million. We increased our dividend and in total returned approximately $1.2 billion to shareholders. We made great progress in our cost reduction programs to offset historically high inflation and energy costs and strengthen our core businesses. We also announced the agreement to sell our Textile Effects business, which we expect to be completed at the end of this month.*

*"Turning to 2023, we are optimistic that destocking will end in the first part of 2023 and fundamentals in our businesses will begin to modestly improve as we move through the year, but visibility into the second half is still low. We are seeing some green shoots in areas like China, automotive, and aerospace, but construction demand globally is still under pressure. Regardless of how much demand improves through the year, we will remain focused on delivering our previously announced cost reduction programs, returning cash to shareholders, and looking for strategic investments to improve our core business while maintaining a strong balance sheet. We look forward to updating you of our progress as we move through 2023."*

**Segment Analysis for 4Q22 Compared to 4Q21**

*Polyurethanes*

The decrease in revenues in our Polyurethanes segment for the three months ended December 31, 2022 compared to the same period of 2021 was primarily due to lower sales volumes and the negative impact of weaker major international currencies against the U.S. dollar, partially offset by higher MDI local prices. Sales volumes decreased primarily due to lower demand, particularly in our European and American regions. The decrease in segment adjusted EBITDA was primarily due to lower sales volumes, lower MDI margins, the negative impact of weaker major international currencies against the U.S. dollar and lower equity earnings from our minority-owned joint venture in China, partially offset by lower fixed costs.

*Performance Products*

The decrease in revenues in our Performance Products segment for the three months ended December 31, 2022 compared to the same period of 2021 was primarily due to lower sales volumes, partially offset by higher average selling prices. Sales volumes decreased due primarily to lower demand for certain products. Average selling prices increased primarily due to commercial excellence programs and in response to an increase in raw material costs. The decrease in segment adjusted EBITDA was primarily due to lower sales volumes.

*Advanced Materials*

The decrease in revenues in our Advanced Materials segment for the three months ended December 31, 2022 compared to the same period of 2021 was primarily due to lower sales volumes, partially offset by higher average selling prices. Sales volumes decreased primarily due to deselection of lower margin business and lower customer demand in industrial markets, partially offset by higher demand in our Aerospace market. Average selling prices increased largely in response to higher raw material, energy, and logistics costs as well as improved sales mix. The decrease in segment adjusted EBITDA was primarily due to lower sales volumes, partially offset by higher sales prices and improved sales mix.

*Corporate, LIFO and other*

For the three months ended December 31, 2022, adjusted EBITDA from Corporate and other was a loss of $52 million as compared to a loss of $50 million for the same period of 2021.

**Liquidity and Capital Resources**

During the three months ended December 31, 2022, our free cash flow from continuing operations was $211 million as compared to $648 million in the same period of 2021. As of December 31, 2022, we had approximately $1.8 billion of combined cash and unused borrowing capacity.

During the three months ended December 31, 2022, we spent $86 million on capital expenditures for continuing operations as compared to $85 million in the same period of 2021. For the year ended December 31, 2022, we spent $272 million on capital expenditures. For 2023, we expect to spend between $240 million to $250 million on capital expenditures.

**Income Taxes**

In 2022, our adjusted effective tax rate was 20%. We expect our 2023 adjusted effective tax rate to be approximately 24% to 26%. We expect our long-term adjusted effective tax rate to be approximately 22% to 24%.

**Earnings Conference Call Information**

We will hold a conference call to discuss our fourth quarter 2022 financial results on Tuesday, February 21, 2023 at 10:00 a.m. ET.

Webcast link: <u>https://event.choruscall.com/mediaframe/webcast.html?webcastid=t1RioKDV</u>

Participant dial-in numbers:

Domestic callers: (877) 402-8037

International callers: (201) 378-4913

The conference call will be accompanied by presentation slides that will be accessible via the webcast link and Huntsman's investor relations website, <u>www.huntsman.com/investors</u>. Upon conclusion of the call, the webcast replay will be accessible via Huntsman's website.

**Upcoming Conferences**

During the first quarter 2023, a member of management is expected to present at:

Alembic Global Advisors Deer Valley Chemical Conference on March 2, 2023

Goldman Sachs Chemical Intensity Day on March 20, 2023

A webcast of the presentation, if applicable, along with accompanying materials will be available at <u>www.huntsman.com/investors</u>.

**Table 1 – Results of Operations**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Twelve months ended** | **Twelve months ended** |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| <br>In millions, except per share amounts | **2022** | **2021** | **2022** | **2021** |
| **Revenues** | $1650 | $2112 | $8023 | $7670 |
| Cost of goods sold | 1460 | 1689 | 6477 | 6086 |
| **Gross profit** | 190 | 423 | 1546 | 1584 |
| Operating expenses, net | 167 | 216 | 788 | 813 |
| Restructuring, impairment and plant closing costs | 50 | 6 | 86 | 40 |
| **Operating (loss) income** | (27) | 201 | 672 | 731 |
| Interest expense, net | (16) | (15) | (62) | (67) |
| Equity in income of investment in unconsolidated affiliates | 12 | 25 | 67 | 143 |
| Fair value adjustments to Venator investment, net | (3) |  | (12) | (28) |
| Loss on early extinguishment of debt |  |  |  | (27) |
| (Costs) income associated with the Albemarle Settlement, net | (3) | 465 | (3) | 465 |
| Other income, net | 12 | 8 | 35 | 29 |
| **(Loss) income from continuing operations before income taxes** | (25) | 684 | 697 | 1246 |
| Income tax expense | (31) | (90) | (186) | (191) |
| **(Loss) income from continuing operations** | (56) | 594 | 511 | 1055 |
| (Loss) income from discontinued operations, net of tax<sup>(3)</sup> | (18) | 13 | 12 | 49 |
| **Net (loss) income** | (74) | 607 | 523 | 1104 |
| Net income attributable to noncontrolling interests, net of tax | (17) | (10) | (63) | (59) |
| **Net (loss) income attributable to Huntsman Corporation** | $(91) | $597 | $460 | $1045 |
| **Adjusted EBITDA<sup>(1)</sup>** | $87 | $327 | $1155 | $1246 |
| **Adjusted net income<sup>(1)</sup>** | $8 | $195 | $636 | $726 |
| **Basic (loss) income per share** | $(0.48) | $2.76 | $2.29 | $4.77 |
| **Diluted (loss) income per share** | $(0.48) | $2.73 | $2.27 | $4.72 |
| **Adjusted diluted income per share<sup>(1)</sup>** | $0.04 | $0.89 | $3.13 | $3.28 |
| **Common share information:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic weighted average shares | 189 | 216 | 201 | 219 |
| &nbsp;&nbsp;&nbsp;Diluted weighted average shares | 189 | 219 | 203 | 221 |
| &nbsp;&nbsp;&nbsp;Diluted shares for adjusted diluted income per share | 190 | 219 | 203 | 221 |

---

*See end of press release for footnote explanations.*

**Table 2 – Results of Operations by Segment**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | | **Twelve months ended** | **Twelve months ended** | |
| | **December 31,** | **December 31,** | | **December 31,** | **December 31,** | |
| <br>In millions | **2022** | **2021** |<br>**Better /**<br>**(Worse)** | **2022** | **2021** |<br>**Better /**<br>**(Worse)** |
| **Segment Revenues:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Polyurethanes | $1071 | $1393 | (23)% | $5067 | $5019 | 1% |
| &nbsp;&nbsp;&nbsp;Performance Products | 307 | 410 | (25)% | 1713 | 1485 | 15% |
| &nbsp;&nbsp;&nbsp;Advanced Materials | 278 | 317 | (12)% | 1277 | 1198 | 7% |
| &nbsp;&nbsp;&nbsp;**Total Reportable Segments' Revenue** | 1656 | 2120 | (22)% | 8057 | 7702 | 5% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intersegment Eliminations | (6) | (8) | n/m | (34) | (32) | n/m |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Revenues** | $1650 | $2112 | (22)% | $8023 | $7670 | 5% |
| **Segment Adjusted EBITDA<sup>(1)</sup>:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Polyurethanes | $37 | $218 | (83)% | $628 | $879 | (29)% |
| &nbsp;&nbsp;&nbsp;Performance Products | 61 | 105 | (42)% | 469 | 359 | 31% |
| &nbsp;&nbsp;&nbsp;Advanced Materials | 41 | 54 | (24)% | 233 | 204 | 14% |
| &nbsp;&nbsp;&nbsp;**Total Reportable Segments' Adjusted EBITDA<sup>(1)</sup>** | 139 | 377 | (63)% | 1330 | 1442 | (8)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Corporate, LIFO and other | (52) | (50) | (4)% | (175) | (196) | 11% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Adjusted EBITDA<sup>(1)</sup>** | $87 | $327 | (73)% | $1155 | $1246 | (7)% |

---

n/m = not meaningful

See end of press release for footnote explanations.

**Table 3 – Factors Impacting Sales Revenue**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | | **Three months ended** | **Three months ended** | **Three months ended** | |
|  | **December 31, 2022 vs. 2021** | **December 31, 2022 vs. 2021** | **December 31, 2022 vs. 2021** | **December 31, 2022 vs. 2021** | **December 31, 2022 vs. 2021** |
|  | **Average Selling Price<sup>(a)</sup>** | **Average Selling Price<sup>(a)</sup>** | | | |
|  | **Local**<br>**Currency** | **Exchange**<br>**Rate** |<br>**Sales**<br>**Volume<sup>(b)</sup>** |<br>**Sales Mix**<br>**& Other** |<br>**Total** |
| Polyurethanes | 5% | (6)% | (22)% | 0% | (23)% |
| Performance Products | 10% | (3)% | (32)% | 0% | (25)% |
| Advanced Materials | 13% | (7)% | (28)% | 10% | (12)% |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | | **Twelve months ended** | **Twelve months ended** | **Twelve months ended** | |
|  | **December 31, 2022 vs. 2021** | **December 31, 2022 vs. 2021** | **December 31, 2022 vs. 2021** | **December 31, 2022 vs. 2021** | **December 31, 2022 vs. 2021** |
|  | **Average Selling Price<sup>(a)</sup>** | **Average Selling Price<sup>(a)</sup>** | | | |
|  | **Local**<br>**Currency** | **Exchange**<br>**Rate** |<br>**Sales**<br>**Volume<sup>(b)</sup>** |<br>**Sales Mix**<br>**& Other** |<br>**Total** |
| Polyurethanes | 16% | (5)% | (10)% | 0% | 1% |
| Performance Products | 27% | (3)% | (11)% | 2% | 15% |
| Advanced Materials | 20% | (5)% | (19)% | 11% | 7% |

---

 

*(a)* *Excludes sales from tolling arrangements, by-products and raw materials.* 

*(b)* *Excludes sales from by-products and raw materials.* 

 

**Table 4 – Reconciliation of U.S. GAAP to Non-GAAP Measures**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | | **Income Tax** | **Income Tax** | **Net** | **Net** | **Diluted (Loss) Income** | **Diluted (Loss) Income** |
| | **EBITDA** | **EBITDA** | **(Expense) Benefit** | **(Expense) Benefit** | **(Loss) Income** | **(Loss) Income** | **Per Share** | **Per Share** |
| | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| <br>In millions, except per share amounts | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Net (loss) income** | $(74) | $607 |  |  | $(74) | $607 | $(0.39) | $2.77 |
| &nbsp;&nbsp;&nbsp;Net income attributable to noncontrolling interests | (17) | (10) |  |  | (17) | (10) | (0.09) | (0.04) |
| **Net income attributable to Huntsman Corporation** | (91) | 597 |  |  | (91) | 597 | (0.48) | 2.73 |
| &nbsp;&nbsp;&nbsp;Interest expense,net from continuing operations | 16 | 15 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Income tax expense from continuing operations | 31 | 90 | $(31) | $(90) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Income tax expense from discontinued operations<sup>(3)</sup> | 5 | 3 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization from continuing operations | 74 | 73 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization from discontinued operations <sup>(3)</sup> | 1 | 4 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Business acquisition and integration expenses and purchase accounting inventory adjustments | 1 | 3 | 1 | (2) | 2 | 1 | 0.01 | - |
| &nbsp;&nbsp;&nbsp;Income associated with the Albemarle Settlement, net |  | (465) |  | 55 |  | (410) |  | (1.87) |
| &nbsp;&nbsp;&nbsp;EBITDA / Loss (income) from discontinued operations, net of tax <sup>(3)</sup> | 12 | (20) | N/A | N/A | 18 | (13) | 0.10 | (0.06) |
| &nbsp;&nbsp;&nbsp;Establishment of significant deferred tax asset valuation allowance <sup>(4)</sup> |  |  | 49 |  | 49 |  | 0.26 | - |
| &nbsp;&nbsp;&nbsp;Gain on sale of businesses/assets | (27) |  | 6 | (1) | (21) | (1) | (0.11) | - |
| &nbsp;&nbsp;&nbsp;Income from transition services arrangements |  | (2) |  | 1 |  | (1) |  | - |
| &nbsp;&nbsp;&nbsp;Fair value adjustments to Venator investment, net | 3 |  |  |  | 3 |  | 0.02 | - |
| &nbsp;&nbsp;&nbsp;Certain legal and other settlements and related (income) expenses | (8) | 3 | 2 |  | (6) | 3 | (0.03) | 0.01 |
| &nbsp;&nbsp;&nbsp;Certain non-recurring information technology project implementation costs | 1 | 2 |  | (1) | 1 | 1 | 0.01 | - |
| &nbsp;&nbsp;&nbsp;Amortization of pension and postretirement actuarial losses | 17 | 18 | (4) | (3) | 13 | 15 | 0.07 | 0.07 |
| &nbsp;&nbsp;&nbsp;Restructuring, impairment and plant closing and transition costs | 52 | 9 | (12) | (3) | 40 | 6 | 0.21 | 0.03 |
| &nbsp;&nbsp;&nbsp;Plant incident remediation credits | - | (3) | - | - | - | (3) | - | (0.01) |
| **Adjusted<sup>(1)</sup>** | $87 | $327 | $11 | $(44) | $8 | $195 | $0.04 | $0.89 |
| Adjusted income tax (benefit) expense<sup>(1)</sup> |  |  |  |  | $(11) | $44 |  |  |
| Net income attributable to noncontrolling interests, net of tax |  |  |  |  | 17 | 10 |  |  |
| **Adjusted pre-tax income <sup>(1)</sup>** |  |  |  |  | $14 | $249 |  |  |
| **Adjusted effective tax rate<sup>(5)</sup>** |  |  |  |  | N/M | 18% |  |  |
| **Effective tax rate** |  |  |  |  | N/M | 13% |  |  |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | | **Income Tax** | **Income Tax** | | | **Diluted Income** | **Diluted Income** |
| | **EBITDA** | **EBITDA** | **(Expense) Benefit** | **(Expense) Benefit** | **Net Income** | **Net Income** | **Per Share** | **Per Share** |
| | **Twelve months ended** | **Twelve months ended** | **Twelve months ended** | **Twelve months ended** | **Twelve months ended** | **Twelve months ended** | **Twelve months ended** | **Twelve months ended** |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| <br>In millions, except per share amounts | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** | **2022** | **2021** |
| **Net income** | $523 | $1104 |  |  | $523 | $1104 | $2.58 | $4.99 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to noncontrolling interests | (63) | (59) |  |  | (63) | (59) | (0.31) | (0.27) |
| **Net income attributable to Huntsman Corporation** | 460 | 1045 |  |  | 460 | 1045 | 2.27 | 4.72 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net from continuing operations | 62 | 67 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense from continuing operations | 186 | 191 | $(186) | $(191) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense from discontinued operations<sup>(3)</sup> | 19 | 21 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization from continuing operations | 281 | 278 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization from discontinued operations <sup>(3)</sup> | 12 | 18 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Business acquisition and integration expenses and purchase accounting inventory adjustments | 12 | 22 | (2) | (6) | 10 | 16 | 0.05 | 0.07 |
| &nbsp;&nbsp;&nbsp;&nbsp;Costs (income) associated with the Albemarle Settlement, net | 3 | (465) | (1) | 55 | 2 | (410) | 0.01 | (1.85) |
| &nbsp;&nbsp;&nbsp;&nbsp;EBITDA / Income from discontinued operations, net of tax <sup>(3)</sup> | (43) | (88) | N/A | N/A | (12) | (49) | (0.06) | (0.22) |
| &nbsp;&nbsp;&nbsp;&nbsp;Establishment of significant deferred tax asset valuation allowance <sup>(4)</sup> |  |  | 49 |  | 49 |  | 0.24 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of businesses/assets |  | (30) |  | 3 |  | (27) |  | (0.12) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income from transition services arrangements | (2) | (8) |  | 2 | (2) | (6) | (0.01) | (0.03) |
| &nbsp;&nbsp;&nbsp;&nbsp;Fair value adjustments to Venator investment,net | 12 | 28 |  |  | 12 | 28 | 0.06 | 0.13 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on early extinguishment of debt |  | 27 |  | (6) |  | 21 |  | 0.09 |
| &nbsp;&nbsp;&nbsp;&nbsp;Certain legal and other settlements and related expenses | 7 | 13 | (2) | (3) | 5 | 10 | 0.02 | 0.05 |
| &nbsp;&nbsp;&nbsp;&nbsp;Certain non-recurring information technology project implementation costs | 5 | 8 | (1) | (2) | 4 | 6 | 0.02 | 0.03 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of pension and postretirement actuarial losses | 49 | 74 | (11) | (16) | 38 | 58 | 0.19 | 0.26 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring, impairment and plant closing and transition costs | 96 | 45 | (23) | (11) | 73 | 34 | 0.36 | 0.15 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plant incident remediation credits | (4) | - | 1 | - | (3) | - | (0.01) | - |
| **Adjusted<sup>(1)</sup>** | $1155 | $1246 | $(176) | $(175) | $636 | $726 | $3.13 | $3.28 |
| Adjusted income tax expense<sup>(1)</sup> |  |  |  |  | $176 | $175 |  |  |
| Net income attributable to noncontrolling interests, net of tax |  |  |  |  | 63 | 59 |  |  |
| **Adjusted pre-tax income<sup>(1)</sup>** |  |  |  |  | $875 | $960 |  |  |
| **Adjusted effective tax rate<sup>(5)</sup>** |  |  |  |  | 20% | 18% |  |  |
| **Effective tax rate** |  |  |  |  | 27% | 15% |  |  |

---

N/A = not applicable

See end of press release for footnote explanations.

**Table 5 – Selected Balance Sheet Items**

---

| | | |
|:---|:---|:---|
| <br>In millions | **December 31,**<br>**2022** | **December 31,**<br>**2021** |
| Cash | $654 | $1041 |
| Accounts and notes receivable, net | 834 | 1015 |
| Inventories | 995 | 1038 |
| Receivable associated with the Albemarle Settlement |  | 333 |
| Other current assets | 190 | 155 |
| Current assets held for sale <sup>(3)</sup> | 472 | 346 |
| Property, plant and equipment, net | 2377 | 2443 |
| Other noncurrent assets | 2698 | 2839 |
| Noncurrent assets held for sale <sup>(3)</sup> | - | 182 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total assets** | $8220 | $9392 |
| Accounts payable | $961 | $1114 |
| Other current liabilities | 480 | 762 |
| Current portion of debt | 66 | 12 |
| Current liabilities held for sale <sup>(3)</sup> | 194 | 163 |
| Long-term debt | 1671 | 1538 |
| Other noncurrent liabilities | 1008 | 1093 |
| Noncurrent liabilities held for sale <sup>(3)</sup> |  | 151 |
| Huntsman Corporation stockholders' equity | 3624 | 4378 |
| Noncontrolling interests in subsidiaries | 216 | 181 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities and equity** | $8220 | $9392 |

---

**Table 6 – Outstanding Debt**

---

| | | |
|:---|:---|:---|
| <br>In millions | **December 31,**<br>**2022** | **December 31,**<br>**2021** |
| **Debt:** |  |  |
| &nbsp;&nbsp;&nbsp;Revolving credit facility | $55 | $- |
| &nbsp;&nbsp;&nbsp;Accounts receivable programs | 166 |  |
| &nbsp;&nbsp;&nbsp;Senior notes | 1455 | 1473 |
| &nbsp;&nbsp;&nbsp;Variable interest entities | 35 | 45 |
| &nbsp;&nbsp;&nbsp;Other debt | 26 | 32 |
| **Total debt - excluding affiliates** | 1737 | 1550 |
| Total cash | 654 | 1041 |
| **Net debt - excluding affiliates<sup>(6)</sup>** | $1083 | $509 |

---

*See end of press release for footnote explanations.*

**Table 7 – Summarized Statement of Cash Flows**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Twelve months ended** | **Twelve months ended** |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| <br>In millions | **2022** | **2021** | **2022** | **2021** |
| **Total cash at beginning of period** | $515 | $505 | $1041 | $1593 |
| &nbsp;&nbsp;Net cash provided by operating activities from continuing operations | 297 | 733 | 892 | 915 |
| &nbsp;&nbsp;Net cash used in operating activities from discontinued operations | 13 | 57 | 22 | 37 |
| &nbsp;&nbsp;Net cash used in investing activities | (84) | (78) | (260) | (508) |
| &nbsp;&nbsp;Net cash provided by investing activities from discontinued operations <sup>(3)</sup> | (7) | (7) | (19) | (16) |
| &nbsp;&nbsp;Net cash used in financing activities | (89) | (168) | (994) | (977) |
| &nbsp;&nbsp;Effect of exchange rate changes on cash | 9 | (1) | (28) | (3) |
| **Total cash at end of period** | $654 | $1041 | $654 | $1041 |
| **Free cash flow from continuing operations<sup>(2)</sup>:** |  |  |  |  |
| &nbsp;&nbsp;Net cash provided by operating activities from continuing operations | $297 | $733 | $892 | $915 |
| &nbsp;&nbsp;Capital expenditures | (86) | (85) | (272) | (326) |
| **Free cash flow from continuing operations** | **211** | **648** | **620** | **589** |
| **Supplemental cash flow information:** |  |  |  |  |
| &nbsp;&nbsp;Cash paid for interest | $(25) | $(25) | $(66) | $(82) |
| &nbsp;&nbsp;Cash paid for income taxes | (23) | (23) | (194) | (106) |
| &nbsp;&nbsp;Cash paid for restructuring and integration | (12) | (4) | (56) | (32) |
| &nbsp;&nbsp;Cash paid for pensions | (10) | (8) | (48) | (53) |
| &nbsp;&nbsp;Depreciation and amortization from continuing operations | 74 | 73 | 281 | 278 |
| &nbsp;&nbsp;Change in primary working capital: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts and notes receivable | $206 | $22 | $146 | $(313) |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 122 | (72) | (6) | (342) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 29 | 212 | (84) | 346 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total change in primary working capital | $357 | $162 | $56 | $(309) |

---

See end of press release for footnote explanations.

**Footnotes**

(1) We use adjusted EBITDA to measure the operating performance of our business
 and for planning and evaluating the performance of our business segments. We provide adjusted
 net income because we feel it provides meaningful insight for the investment community into
 the performance of our business. We believe that net income (loss) is the performance measure
 calculated and presented in accordance with generally accepted accounting principles in the
 U.S. ("GAAP") that is most directly comparable to adjusted EBITDA and adjusted
 net income (loss). Additional information with respect to our use of each of these financial
 measures follows:

Adjusted EBITDA, adjusted net income (loss) and adjusted diluted income (loss) per share, as used herein, are not necessarily comparable to other similarly titled measures of other companies.

Adjusted EBITDA is computed by eliminating the following from net income (loss): (a) net income attributable to noncontrolling interests, net of tax; (b) interest; (c) income taxes; (d) depreciation and amortization; (e) amortization of pension and postretirement actuarial losses (gains); (f) restructuring, impairment and plant closing and transition costs (credits); and further adjusted for certain other items set forth in the reconciliation of net income (loss) to adjusted EBITDA in Table 4 above.

Adjusted net income (loss) and adjusted diluted income (loss) per share are computed by eliminating the after tax impact of the following items from net income (loss): (a) net income attributable to noncontrolling interest; (b) amortization of pension and postretirement actuarial losses (gains); (c) restructuring, impairment and plant closing and transition costs (credits); and further adjusted for certain other items set forth in the reconciliation of net income (loss) to adjusted net income (loss) in Table 4 above. The income tax impacts, if any, of each adjusting item represent a ratable allocation of the total difference between the unadjusted tax expense and the total adjusted tax expense, computed without consideration of any adjusting items using a with and without approach.

We may disclose forward-looking adjusted EBITDA because we cannot adequately forecast certain items and events that may or may not impact us in the near future, such as business acquisition and integration expenses and purchase accounting inventory adjustments, certain legal and other settlements and related expenses, gains on sale of businesses/assets and certain tax only items, including tax law changes not yet enacted. Each of such adjustment has not yet occurred, is out of our control and/or cannot be reasonably predicted. In our view, our forward-looking adjusted EBITDA represents the forecast net income on our underlying business operations but does not reflect any adjustments related to the items noted above that may occur and can cause our adjusted EBITDA to differ.

(2) Management internally uses free cash flow measure: (a) to evaluate
 our liquidity, (b) evaluate strategic investments, (c) plan stock buyback and dividend
 levels and (d) evaluate our ability to incur and service debt. Free cash flow is defined
 as net cash provided by operating activities less capital expenditures. Free cash flow is
 not a defined term under U.S. GAAP, and it should not be inferred that the entire free cash
 flow amount is available for discretionary expenditures.

(3) During the third quarter 2022, we entered into an agreement to sell our
 Textile Effects business, which is now reported as discontinued operations on the income
 and cash flow statements and held for sale on the balance sheet.

(4) During the fourth quarter
 2022, we established a $49 million significant deferred tax asset valuation allowance in
 The Netherlands. We eliminated the effect of this significant change in deferred tax asset
 valuation allowances from our presentation of adjusted net income to allow investors to better
 compare our ongoing financial performance from period to period.

(5) We believe adjusted effective
 tax rate provides improved comparability between periods through the exclusion of certain
 items that management believes are not indicative of the businesses' operational profitability
 and that may obscure underlying business results and trends. In our view, effective tax rate
 is the performance measure calculated and presented in accordance with U.S. GAAP that is
 most directly comparable to adjusted effective tax rate. The reconciliation of historical
 adjusted effective tax rate and effective tax rate is set forth in Table 4 above. Please
 see the reconciliation of our net income to adjusted net income in Table 4 for details regarding
 the tax impacts of our non-GAAP adjustments.

Our forward-looking adjusted effective tax rate is calculated based on our forecast effective tax rate, and the range of our forward-looking adjusted effective tax rate equals the range of our forecast effective tax rate. We disclose forward-looking adjusted effective tax rate because we cannot adequately forecast certain items and events that may or may not impact us in the near future, such as business acquisition and integration expenses and purchase accounting inventory adjustments, certain legal and other settlements and related expenses, gains on sale of businesses/assets and certain tax only items, including tax law changes not yet enacted. Each of such adjustment has not yet occurred, is out of our control and/or cannot be reasonably predicted. In our view, our forward-looking adjusted effective tax rate represents the forecast effective tax rate on our underlying business operations but does not reflect any adjustments related to the items noted above that may occur and can cause our effective tax rate to differ.

(6) Net debt is a measure
 we use to monitor how much debt we have after taking into account our total cash. We use
 it as an indicator of our overall financial position, and calculate it by taking our total
 debt, including the current portion, and subtracting total cash.

**About Huntsman:**

*Huntsman Corporation is a publicly traded global manufacturer and marketer of differentiated and specialty chemicals with 2022 revenues of approximately $8 billion from our continuing operations. Our chemical products number in the thousands and are sold worldwide to manufacturers serving a broad and diverse range of consumer and industrial end markets. We operate more than 60 manufacturing, R&D and operations facilities in approximately 30 countries and employ approximately 7,000 associates within our continuing operations. For more information about Huntsman, please visit the company's website at <u>www.huntsman.com</u>.*

**Social Media:**

*Twitter: <u>www.twitter.com/Huntsman_Corp</u><br> Facebook: <u>www.facebook.com/huntsmancorp</u><br> LinkedIn: <u>www.linkedin.com/company/huntsman</u>*

**Forward-Looking Statements:**

*This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements include statements concerning our plans, objectives, goals, strategies, future events, future revenue or performance, capital expenditures, financing needs, plans or intentions relating to acquisitions, divestitures or strategic transactions, including the sale of the Textile Effects Division, business trends and any other information that is not historical information. When used in this press release, the words "estimates," "expects," "anticipates," "likely," "projects," "outlook," "plans," "intends," "believes," "forecasts," or future or conditional verbs, such as "will," "should," "could" or "may," and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements, including, without limitation, management's examination of historical operating trends and data, are based upon our current expectations and various assumptions and beliefs. In particular, such forward-looking statements are subject to uncertainty and changes in circumstances and involve risks and uncertainties that may affect the Company's operations, markets, products, prices and other factors as discussed in the Company's filings with the Securities and Exchange Commission (the "SEC"). Significant risks and uncertainties may relate to, but are not limited to, increased energy costs in Europe, inflation and resulting monetary tightening in the US, geopolitical instability, ongoing impact of COVID-19 on our operations and financial results, volatile global economic conditions, cyclical and volatile product markets, disruptions in production at manufacturing facilities, timing of proposed transactions including the sale of our Textile Effects business, reorganization or restructuring of the Company's operations, including any delay of, or other negative developments affecting the ability to implement cost reductions and manufacturing optimization improvements in the Company's businesses and to realize anticipated cost savings, and other financial, operational, economic, competitive, environmental, political, legal, regulatory and technological factors. Any forward-looking statement should be considered in light of the risks set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022, which may be supplemented by other risks and uncertainties disclosed in any subsequent reports filed or furnished by the Company from time to time. All forward-looking statements apply only as of the date made. Except as required by law, the Company undertakes no obligation to update or revise forward-looking statements to reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events.*